Рет қаралды 1,967
Eli Lilly chairman and CEO Dave Ricks says the company is working on expanding its medicine supply as the global obesity rate increases. Speaking with Bloomberg's Caroline Hyde at the Economic Club of New York, Ricks says the company is looking to create an oral tablet in addition to an injectable device and hopes to get them to market quicker.
Follow Bloomberg for business news & analysis, up-to-the-minute market data, features, profiles and more: www.bloomberg.com
Connect with us on...
Twitter: / business
Facebook: / bloombergbusiness
Instagram: quicktake?...